Aperçu des produits pour PLA2G6 (PLA2G6) Kits ELISA

Full name:
phospholipase A2, Group VI (Cytosolic, Calcium-Independent) Kits ELISA (PLA2G6)
Chez www.anticorps-enligne.fr sont 12 phospholipase A2, Group VI (Cytosolic, Calcium-Independent) (PLA2G6) Kits ELISA de 6 de différents fournisseurs disponibles. De plus, nous expédions PLA2G6 Anticorps (38) et PLA2G6 Protéines (8) et beaucoup plus de produits pour cette protéine. Un total de 62 PLA2G6 produits sont actuellement listés.
Synonymes:
BB112799, CaI-PLA2, GVI, INAD1, iPLA(2)beta, iPla2, IPLA2-VIA, iPLA2beta, MGC83523, NBIA2, NBIA2A, NBIA2B, PARK14, PLA2, PLA2G6, PNPLA9, wu:fc06g09, zgc:77476

PLA2G6 (PLA2G6) Kits ELISA par réactivité

Select your species

PLA2G6 Kits ELISA mieux référencés

  1. Human PLA2G6 Kit ELISA pour Sandwich ELISA - ABIN414975 : Lee, Park, Son, Song, Kim, Ko, Song, Lee, Yoon, Ham, Han, Hong: Anti-cancer effect of snake venom toxin through down regulation of AP-1 mediated PRDX6 expression. dans Oncotarget 2015 (PubMed)

Plus Kits ELISA pour PLA2G6 partenaires d'interaction

Mouse (Murine) phospholipase A2, Group VI (Cytosolic, Calcium-Independent) (PLA2G6) interaction partners

  1. Time lapse microscopy and integrin endocytosis assay revealed the essential role of calcium-independent phospholipase A2 (Montrer LYPLA1 Kits ELISA) activity for the recycling of alpha 6 integrin-GFP from the endosomal recycling complex to the plasma membrane.

  2. iPLA2-gamma (Montrer PNPLA8 Kits ELISA) has a protective functional role in the normal glomerulus and in glomerulonephritis.

  3. Results suggest that the degeneration of dopaminergic neurons occurs mainly in the distal region of axons in iPLA2beta-KO mice.

  4. This study showed that the absence of iPLA2beta activity does not influence myocardial inflammation, but iPLA2beta is essential for T. cruzi clearance.

  5. Results support the deleterious role of iPLA2beta in severe obesity associated NAFLD (Montrer TSC2 Kits ELISA).

  6. Genetic or molecular impairment of PLA2g6-dependent Ca(2+) signalling is a trigger for autophagic dysfunction, progressive loss of dopamine (Montrer CA2 Kits ELISA)rgic (DA) neurons in substantia nigra pars compacta and age-dependent L-DOPA-sensitive motor dysfunction.

  7. An inactivation of iPLA2beta exacerbated pathogenesis of experimental colitis by promoting intestinal epithelial cell apoptosis, inhibiting crypt cell regeneration, and causing damage to mucus barrier allowing an activation of innate immune response.

  8. diapocynin inhibited ROS (Montrer ROS1 Kits ELISA) production, abolished iPLA2 activity and reduced Ca2 (Montrer CA2 Kits ELISA)+ influx through stretch-activated and store-operated channels, two major pathways responsible for excessive Ca2 (Montrer CA2 Kits ELISA)+ entry in dystrophic muscle

  9. Mice deficient in iPLA2Beta show evidence of neuroinflammation and motor dysfunction in later life.

  10. membrane potential sensitive activity is the iPLA2gamma (Montrer PNPLA8 Kits ELISA)

Human phospholipase A2, Group VI (Cytosolic, Calcium-Independent) (PLA2G6) interaction partners

  1. A novel missense mutation in PLA2G6 gene (c.3G > T:p.M1I) in one and half-year-old boy with muscle weakness and neurodevelopmental regression (speech, motor and cognition).

  2. PLA2G6 mutations in Indian patients with infantile neuroaxonal dystrophy (Montrer SPTBN4 Kits ELISA) and atypical late-onset neuroaxonal dystrophy (Montrer SPTBN4 Kits ELISA)

  3. These results strongly suggest that PNPLA9, -6 and -4 play a key role in GPL (Montrer IL31RA Kits ELISA) turnover and homeostasis in human cells. A hypothetical model suggesting how these enzymes could recognize the relative concentration of the different GPLs is proposed

  4. This study identifies a novel PLA2G6 mutation that is the possible genetic cause of FCMTE in this Chinese family.

  5. Finding suggest the broadness of the clinical spectrum of group VI phospholipases A2 (PLA2G6)-related neurodegeneration.

  6. A homozygous novel mutation at position c.2277-1G>C in PLA2G6 gene presumed to give rise to altered splicing, was detected, thus confirming the diagnosis of infantile Neuroaxonal Dystrophy (Montrer SPTBN4 Kits ELISA) (INAD (Montrer INADL Kits ELISA)).

  7. Three catalytically active cPLA2 (Montrer PLA2G4A Kits ELISA), iPLA2, and sPLA2 (Montrer PLA2G2A Kits ELISA) are expressed in different areas within the human spermatozoon cell body. Spermatozoa with a significant low motility showed strong differences both in terms of total specific activity and of different intracellular distribution, compared with normal spermatozoa. Phospholipases could be potential biomarkers of asthenozoospermia.

  8. This study demonstrated that elevated expression of alphaSyn/PalphaSyn in mitochondria appears to be the early response to PLA2G6-deficiency in neurons.

  9. Stimulation of adrenoreceptors causes increased iPLA2 expression via MAP kinase/ERK (Montrer MAPK1 Kits ELISA) 1 (Montrer MAPK3 Kits ELISA)/2.

  10. genetic association study in Quebec City population: Data suggest total plasma n-6 fatty acid phospholipid levels and C-reactive protein (Montrer CRP Kits ELISA) are modulated by SNPs in PLA2G4A (Montrer PLA2G4A Kits ELISA) and PLA2G6 alone or in combination with fish oil dietary supplementation.

PLA2G6 profil antigène

Antigen Summary

The protein encoded by this gene is an A2 phospholipase, a class of enzyme that catalyzes the release of fatty acids from phospholipids. The encoded protein may play a role in phospholipid remodelling, arachidonic acid release, leukotriene and prostaglandin synthesis, fas-mediated apoptosis, and transmembrane ion flux in glucose-stimulated B-cells. Several transcript variants encoding multiple isoforms have been described, but the full-length nature of only three of them have been determined to date.

Alternative names and synonyms associated with PLA2G6

  • phospholipase A2, group VI (cytosolic, calcium-independent) (pla2g6) Elisa Kit
  • phospholipase A2, group VI (cytosolic, calcium-independent) (PLA2G6) Elisa Kit
  • phospholipase A2, group 6 (cytosolic, calcium-independent) (pla2g6) Elisa Kit
  • phospholipase A2, group VI (Pla2g6) Elisa Kit
  • phospholipase A2, group VI (cytosolic, calcium-independent) (Pla2g6) Elisa Kit
  • BB112799 Elisa Kit
  • CaI-PLA2 Elisa Kit
  • GVI Elisa Kit
  • INAD1 Elisa Kit
  • iPLA(2)beta Elisa Kit
  • iPla2 Elisa Kit
  • IPLA2-VIA Elisa Kit
  • iPLA2beta Elisa Kit
  • MGC83523 Elisa Kit
  • NBIA2 Elisa Kit
  • NBIA2A Elisa Kit
  • NBIA2B Elisa Kit
  • PARK14 Elisa Kit
  • PLA2 Elisa Kit
  • PLA2G6 Elisa Kit
  • PNPLA9 Elisa Kit
  • wu:fc06g09 Elisa Kit
  • zgc:77476 Elisa Kit

Protein level used designations for PLA2G6

85 kDa calcium-independent phospholipase A2 , patatin-like phospholipase domain containing 9 , phospholipase A2, group 6 (cytosolic, calcium-independent) , phospholipase A2, group VI (cytosolic, calcium-independent) , 85 kDa calcium-independent phospholipase A2-like , 85/88 kDa calcium-independent phospholipase A2 , GVI PLA2 , caI-PLA2 , group VI phospholipase A2 , iPLA2-beta , intracellular membrane-associated calcium-independent phospholipase A2 beta , patatin-like phospholipase domain-containing protein 9 , calcium-independent phospholipase A2 , cytosolic, calcium-independent phospholipase A2 , neurodegeneration with brain iron accumulation 2

GENE ID SPECIES
406370 Danio rerio
418028 Gallus gallus
446689 Xenopus laevis
481256 Canis lupus familiaris
700184 Macaca mulatta
100055064 Equus caballus
100415535 Callithrix jacchus
100445065 Pongo abelii
100515081 Sus scrofa
100549498 Meleagris gallopavo
100605211 Nomascus leucogenys
53357 Mus musculus
8398 Homo sapiens
535381 Bos taurus
101103799 Ovis aries
360426 Rattus norvegicus
Fournisseurs de qualité sélectionnés pour PLA2G6 (PLA2G6) Kits ELISA
Avez-vous cherché autre chose?